Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Solassol

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Biomolecules|November 2, 2019
FDA- and EMA-Approved Tyrosine Kinase Inhibitors in Advanced <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer: Safety, Tolerability, Plasma Concentration Monitoring, and ManagementIsabelle Solassol, Frédéric Pinguet, Xavier Quantin
Expert Review of Proteomics|July 5, 2019
Protein interactions study through proximity-labelingBenoît Béganton, Isabelle Solassol, Alain Mangé, et al.
Anticancer Research|July 11, 2006
In vitro cytotoxic effect of melphalan and pilot phase II study in hormone-refractory prostate cancerPhilippe Mougenot, Françoise Bressolle, Stéphane Culine, et al.
Translational Lung Cancer Research|January 10, 2022
EGFR-dependent mechanisms of resistance to osimertinib determined by ctDNA NGS analysis identify patients with better outcomeJulie A Vendrell, Xavier Quantin, Audrey Aussel, et al.
Therapeutic Drug Monitoring|July 27, 2005
Inter- and intraindividual variabilities in pharmacokinetics of fentanyl after repeated 72-hour transdermal applications in cancer pain patientsIsabelle Solassol, Françoise Bressolle, Laetitia Caumette, et al.
Clinical Chemistry|July 19, 2008
HPLC with UV or mass spectrometric detection for quantifying endogenous uracil and dihydrouracil in human plasmaRūta Svobaite, Isabelle Solassol, Frederic Pinguet, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2009
Involvement of gene polymorphisms of the folate pathway enzymes in gene expression and anticancer drug sensitivity using the NCI-60 panel as a modelVirginie Charasson, Dominique Hillaire-Buys, Isabelle Solassol, et al.
Oncology Reports|September 6, 2005
Inter- and intra-individual variability in transdermal fentanyl absorption in cancer pain patientsIsabelle Solassol, Laetitia Caumette, Françoise Bressolle, et al.
Journal of Separation Science|April 29, 2009
Quantitation of imidazo[1,2-a]quinoxaline derivatives in human and rat plasma using LC/ESI-MSSonia Khier, Georges Moarbess, Carine Deleuze-Masquefa, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 22, 2025
An Optimized Next-Generation Sequencing Method for Detecting De Novo MET Amplification in Non-Small Cell Lung Cancer: Prognostic and Therapeutic ImplicationsSimon Cabello-Aguilar, Julie A Vendrell, Solène Evrard, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biomolecules|November 2, 2019
FDA- and EMA-Approved Tyrosine Kinase Inhibitors in Advanced <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer: Safety, Tolerability, Plasma Concentration Monitoring, and ManagementIsabelle Solassol, Frédéric Pinguet, Xavier Quantin
Expert Review of Proteomics|July 5, 2019
Protein interactions study through proximity-labelingBenoît Béganton, Isabelle Solassol, Alain Mangé, et al.
Anticancer Research|July 11, 2006
In vitro cytotoxic effect of melphalan and pilot phase II study in hormone-refractory prostate cancerPhilippe Mougenot, Françoise Bressolle, Stéphane Culine, et al.
Translational Lung Cancer Research|January 10, 2022
EGFR-dependent mechanisms of resistance to osimertinib determined by ctDNA NGS analysis identify patients with better outcomeJulie A Vendrell, Xavier Quantin, Audrey Aussel, et al.
Therapeutic Drug Monitoring|July 27, 2005
Inter- and intraindividual variabilities in pharmacokinetics of fentanyl after repeated 72-hour transdermal applications in cancer pain patientsIsabelle Solassol, Françoise Bressolle, Laetitia Caumette, et al.
Clinical Chemistry|July 19, 2008
HPLC with UV or mass spectrometric detection for quantifying endogenous uracil and dihydrouracil in human plasmaRūta Svobaite, Isabelle Solassol, Frederic Pinguet, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2009
Involvement of gene polymorphisms of the folate pathway enzymes in gene expression and anticancer drug sensitivity using the NCI-60 panel as a modelVirginie Charasson, Dominique Hillaire-Buys, Isabelle Solassol, et al.
Oncology Reports|September 6, 2005
Inter- and intra-individual variability in transdermal fentanyl absorption in cancer pain patientsIsabelle Solassol, Laetitia Caumette, Françoise Bressolle, et al.
Journal of Separation Science|April 29, 2009
Quantitation of imidazo[1,2-a]quinoxaline derivatives in human and rat plasma using LC/ESI-MSSonia Khier, Georges Moarbess, Carine Deleuze-Masquefa, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 22, 2025
An Optimized Next-Generation Sequencing Method for Detecting De Novo MET Amplification in Non-Small Cell Lung Cancer: Prognostic and Therapeutic ImplicationsSimon Cabello-Aguilar, Julie A Vendrell, Solène Evrard, et al.
Pageof 2